The Targacept Building in Winston-Salem. Targacept, which is still working on its treatments for central neverous system disorders, was one of Academy Funds portfolio companies.

WINSTON-SALEM, NC – Academy Funds, which raised two small venture capital funds ten years ago, has closed down. The firm’s Web site is not longer active and goes to a hosting service.

Academy focused on North Carolina companies.

The Winston-Salem based funds portfolio companies included Admetech; Amplistar Inc.; Anasazi; Curry Pharmaceuticals; Kucera Pharmaceutical Company; Pilot Therapeutics Inc.; Targacept Inc.; and VetXcel.

It invested primarily in seed, and A and B round deals.

It focused on therapeutics, vaccines, diagnostics, medical devices, platform technologies, agriculture, chemicals/reagents and supplies.

Related Stories:

• Kucera Pharmaceutical Company Receives 6th U.S. Patent
• Kucera Pharmaceutical announces discovery of compound for the potential treatment of SARS
• Kucera Pharmaceutical awarded grant
• NC’s Targacept upgrading equipment with BB&T loan
• Astra Zenieca pays $2M to NC’s Targacept to option product

© 2010, TechJournal. All rights reserved.

Tags: Academy Funds, Biotech, NC, Targacept, Winston Salem